Laura Sutcliffe
Stock Analyst at Citigroup
(0.43)
# 4,291
Out of 5,245 analysts
10
Total ratings
27.27%
Success rate
-12.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $345 → $340 | $208.05 | +63.42% | 5 | Apr 9, 2026 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $9.47 | +137.59% | 4 | Feb 24, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $806.46 | -51.64% | 1 | Jun 18, 2021 |
ResMed
Apr 9, 2026
Maintains: Buy
Price Target: $345 → $340
Current: $208.05
Upside: +63.42%
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $9.47
Upside: +137.59%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $806.46
Upside: -51.64%